Jazz Pharmaceuticals

ZEPZELCA

Manufacturer:

Jazz Pharmaceuticals

Zepzelca HCPCS:

J9223

HCPCS Code Descriptor:

Injection, lurbinectedin, 0.1 mg

Category:

J Code

Zepzelca NDCs:

68727-0712-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zepzelca:

ZEPZELCA is an Oncology drug manufactured by Jazz Pharmaceuticals and administered via the Intravenous route of administration. The J Code: J9223 is aligned to the drug ZEPZELCA.

ACCESS PRICING AND MORE BY REGISTERING

J9223 Added Date:

January 1, 2021

J9223 Effective Date:

January 1, 2021

J9223 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Zepzelca billing and coding information.
Zepzelca patient assistance information can be found through JazzCares at the URL: https://www.jazzcares.com/
ZEPZELCA prescribing information can be found at the link below:
Information regarding ZEPZELCA’s side effects can be found at MedlinePlus